These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35305164)

  • 1. Furanonyl amino acid derivatives as hemostatic drugs: design, synthesis and hemostasis performance.
    Wang N; Lin JY; Luo SH; Zhou YJ; Yang K; Chen RH; Yang GX; Wang ZY
    Amino Acids; 2022 Jul; 54(7):989-999. PubMed ID: 35305164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid-loaded hemostatic nanoclay microsphere frameworks.
    Denry I; Nédélec JM; Holloway JA
    J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):422-430. PubMed ID: 34288380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of amino acid derivatives of 5-alkoxy-3,4-dihalo-2(5H)-furanones and their preliminary bioactivity investigation as linkers.
    Luo SH; Yang K; Lin JY; Gao JJ; Wu XY; Wang ZY
    Org Biomol Chem; 2019 May; 17(20):5138-5147. PubMed ID: 31073571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of tranexamic acid-loaded porous starch and evaluation of its hemostatic ability].
    Xi CY; Zhuang Y; Chen LF; Liu YQ; Wang SF; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):503-8. PubMed ID: 24763031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostatic efficacy of tranexamic acid and ε-aminocaproic acid in hip and knee arthroplasty:a Meta-analysis].
    Zhang J; Yang ZQ
    Zhongguo Gu Shang; 2022 May; 35(5):484-90. PubMed ID: 35535540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid (class I drug) reduced and capped gold nanoparticles as a potential hemostatic agent with enhanced performance.
    Jha CB; Singh C; Patil P; Manna K; Singh S; Varshney R; Mathur R
    Nanotechnology; 2023 Dec; 35(9):. PubMed ID: 37995371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles.
    Li D; Li P; Zang J; Liu J
    J Biomed Biotechnol; 2012; 2012():981321. PubMed ID: 23193369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Evaluation of Tranexamic Acid-Loaded Porous Starch as a Hemostatic Powder.
    Xi C; Zhu L; Zhuang Y; Wang S; Sun G; Liu Y; Wang D
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):279-286. PubMed ID: 28731369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Hemostatic Activity of New Amide Derivatives.
    Banach L; Janczewski L; Kajdanek J; Milowska K; Kolodziejczyk-Czepas J; Galita G; Rozpedek-Kaminska W; Kucharska E; Majsterek I; Kolesinska B
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The naturally occurring furanones: formation and function from pheromone to food.
    Colin Slaughter J
    Biol Rev Camb Philos Soc; 1999 Aug; 74(3):259-76. PubMed ID: 10466251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DBDMH-Promoted Methylthiolation in DMSO: A Metal-Free Protocol to Methyl Sulfur Compounds with Multifunctional Groups.
    Zhou YJ; Fang YG; Yang K; Lin JY; Li HQ; Chen ZJ; Wang ZY
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iota-carrageenan/xyloglucan/serine powders loaded with tranexamic acid for simultaneously hemostatic, antibacterial, and antioxidant performance.
    de Moraes FM; Philippi JV; Belle F; da Silva FS; Morisso FDP; Volz DR; Ziulkoski AL; Bobinski F; Zepon ΚM
    Biomater Adv; 2022 Jun; 137():212805. PubMed ID: 35929232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up study on the hemostatic effect of the Vasolamin preparation in domestic animals].
    Balun J; Sutta J; Janda J
    Vet Med (Praha); 1976 Feb; 21(2):119-24. PubMed ID: 820038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid hemostasis in a sheep model using particles that propel thrombin and tranexamic acid.
    R Baylis J; Finkelstein-Kulka A; Macias-Valle L; Manji J; Lee M; Levchenko E; Okpaleke C; Al-Salihi S; Javer A; J Kastrup C
    Laryngoscope; 2017 Apr; 127(4):787-793. PubMed ID: 27861945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of N-2(5H)-furanonyl sulfonyl hydrazone derivatives and their biological evaluation in vitro and in vivo activity against MCF-7 breast cancer cells.
    Yang K; Yang JQ; Luo SH; Mei WJ; Lin JY; Zhan JQ; Wang ZY
    Bioorg Chem; 2021 Feb; 107():104518. PubMed ID: 33303210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharide Based Hemostatic Strategy for Ultrarapid Hemostasis.
    Chen Y; Wu L; Li P; Hao X; Yang X; Xi G; Liu W; Feng Y; He H; Shi C
    Macromol Biosci; 2020 Apr; 20(4):e1900370. PubMed ID: 32068950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis-2(5H)-furanone derivatives as new anticancer agents: Design, synthesis, biological evaluation, and mechanism studies.
    Wu YC; Cao L; Mei WJ; Wu HQ; Luo SH; Zhan HY; Wang ZY
    Chem Biol Drug Des; 2018 Jul; 92(1):1232-1240. PubMed ID: 29469985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteria-engineered porous sponge for hemostasis and vascularization.
    Bian J; Bao L; Gao X; Wen X; Zhang Q; Huang J; Xiong Z; Hong FF; Ge Z; Cui W
    J Nanobiotechnology; 2022 Jan; 20(1):47. PubMed ID: 35062972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic agents.
    Levy JH
    Transfusion; 2004 Dec; 44(12 Suppl):58S-62S. PubMed ID: 15585007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.